{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:56:02Z","timestamp":1771264562266,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Asper Endowment Foundation"},{"name":"St. Boniface Research Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejase.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Echocardiography"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.echo.2018.09.019","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T08:17:25Z","timestamp":1542442645000},"page":"267-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers"],"prefix":"10.1016","volume":"32","author":[{"given":"Lara F.","family":"Nhola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar S.","family":"Abdelmoneim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector R.","family":"Villarraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Grothey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly-Ann","family":"Bordun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Barros-Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davinder S.","family":"Jassal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Mulvagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.echo.2018.09.019_bib1","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/CIRCULATIONAHA.115.010484","article-title":"Cardio-oncology: how new targeted cancer therapies and precision medicine can inform cardiovascular discovery","volume":"132","author":"Bellinger","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.echo.2018.09.019_bib2","first-page":"831","article-title":"Canadian Cardiovascular Society guidelines for evaluation and management of cardiovascular complications of cancer therapy","volume":"32","author":"Virani","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.echo.2018.09.019_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.echo.2018.09.019_bib4","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2018.09.019_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2018.09.019_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/iju.12502","article-title":"Current management and future perspectives of metastatic renal cell carcinoma","volume":"21","author":"Lee-Ying","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.echo.2018.09.019_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5489\/cuaj.2894","article-title":"Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update","volume":"9","author":"North","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.echo.2018.09.019_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ctrv.2016.12.002","article-title":"Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis","volume":"53","author":"Abdel-Qadir","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.echo.2018.09.019_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchf.2012.09.001","article-title":"The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients","volume":"1","author":"Hall","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.echo.2018.09.019_bib10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","article-title":"Evaluation and management of patients with heart disease and cancer: cardio-oncology","volume":"89","author":"Herrmann","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.echo.2018.09.019_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2796.2001.00820.x","article-title":"Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy","volume":"249","author":"Nousiainen","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.echo.2018.09.019_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM197902083000603","article-title":"Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography","volume":"300","author":"Alexander","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.echo.2018.09.019_bib13","first-page":"797","article-title":"Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography","volume":"26","author":"Villani","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.echo.2018.09.019_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000227621","article-title":"Review of tests for monitoring doxorubicin-induced cardiomyopathy","volume":"53","author":"Ganz","year":"1996","journal-title":"Oncology"},{"key":"10.1016\/j.echo.2018.09.019_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/ctrv.1999.0128","article-title":"Detection of anthracycline-induced cardiotoxicity","volume":"25","author":"Meinardi","year":"1999","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.echo.2018.09.019_bib16","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"Fallah-Rad","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.09.019_bib17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","article-title":"Early detection and prediction of cardiotoxicity in chemotherapy-treated patients","volume":"107","author":"Sawaya","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.echo.2018.09.019_bib18","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","article-title":"Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review","volume":"63","author":"Thavendiranathan","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.09.019_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.09.019_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc of Echocardiogr"},{"key":"10.1016\/j.echo.2018.09.019_bib21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2007.01.078","article-title":"Tissue Doppler imaging a new prognosticator for cardiovascular diseases","volume":"49","author":"Yu","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.09.019_bib22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10554-012-0120-7","article-title":"Left and right ventricular strain and strain rate measurement in normal adults using Velocity Vector Imaging: an assessment of reference values and intersystem agreement","volume":"29","author":"Fine","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2018.09.019_bib23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.echo.2018.09.019_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ahj.2013.01.011","article-title":"The evaluation and management of drug effects on cardiac conduction (PR and QRS intervals) in clinical development","volume":"165","author":"Nada","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.echo.2018.09.019_bib25","first-page":"e002661","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging","volume":"9","author":"Bloom","year":"2016","journal-title":"Cir Heart Fail"},{"key":"10.1016\/j.echo.2018.09.019_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/ehjci\/jew160","article-title":"Predicting outcomes after percutaneous mitral balloon valvotomy: the impact of left ventricular strain imaging","volume":"18","author":"Barros-Gomes","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.echo.2018.09.019_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","article-title":"Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity","volume":"26","author":"Negishi","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.echo.2018.09.019_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.critrevonc.2014.12.008","article-title":"Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"94","author":"Ghatalia","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.echo.2018.09.019_bib29","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1158\/1078-0432.CCR-16-2869","article-title":"Prospective evaluation of sunitinib-induced cardiotoxicity in patients with metastatic renal cell carcinoma","volume":"23","author":"Narayan","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.echo.2018.09.019_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-016-0514-0","article-title":"Tyrosine kinase inhibitors and vascular toxicity: impetus for a classification system?","volume":"18","author":"Herrmann","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.echo.2018.09.019_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/eurjhf\/hft008","article-title":"The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors","volume":"15","author":"Tocchetti","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.echo.2018.09.019_bib32","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.09.019_bib33","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.echo.2018.09.019_bib34","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/cncr.23460","article-title":"Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor","volume":"112","author":"Khakoo","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.echo.2018.09.019_bib35","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/annonc\/mdn168","article-title":"Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate","volume":"19","author":"Telli","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.echo.2018.09.019_bib36","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.echo.2018.09.019_bib37","doi-asserted-by":"crossref","first-page":"H692","DOI":"10.1152\/ajpheart.00172.2015","article-title":"The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity","volume":"309","author":"Bordun","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.echo.2018.09.019_bib38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jcmg.2018.03.019","article-title":"Rationale and design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes (SUCCOUR) trial","volume":"11","author":"Negishi","year":"2018","journal-title":"JACC Cardivasc Imaging"},{"key":"10.1016\/j.echo.2018.09.019_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/HYPERTENSIONAHA.109.149690","article-title":"Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels","volume":"56","author":"Kappers","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.echo.2018.09.019_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/annonc\/mdn637","article-title":"Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab","volume":"20","author":"Scartozzi","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.echo.2018.09.019_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11936-016-0452-z","article-title":"Anti-VEGF-induced hypertension: a review of pathophysiology and treatment options","volume":"18","author":"Brinda","year":"2016","journal-title":"Curr Treat Options Cardiovascular Med"},{"key":"10.1016\/j.echo.2018.09.019_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11912-012-0242-z","article-title":"VEGF inhibition, hypertension, and renal toxicity","volume":"14","author":"Hayman","year":"2012","journal-title":"Curr Onc Rep"},{"key":"10.1016\/j.echo.2018.09.019_bib43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2012.02.053","article-title":"Cardiovascular and systemic microvascular effects of anti-vascular endothelial grown factor therapy for cancer","volume":"60","author":"Belcik","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.echo.2018.09.019_bib44","first-page":"160","article-title":"Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines","volume":"30","author":"Pudil","year":"2008","journal-title":"Exp Oncol"},{"key":"10.1016\/j.echo.2018.09.019_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchf.2017.08.024","article-title":"Left ventricular dysfunction in cancer treatment: is it relevant?","volume":"6","author":"Kenigsberg","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.echo.2018.09.019_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.echo.2017.11.018","article-title":"Echocardiography core laboratory reproducibility of cardiac safety assessments in cardio-oncology","volume":"31","author":"Khouri","year":"2018","journal-title":"J Am Soc Echocardiogr"}],"container-title":["Journal of the American Society of Echocardiography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0894731718305376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0894731718305376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:03:51Z","timestamp":1760245431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0894731718305376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0894731718305376"],"URL":"https:\/\/doi.org\/10.1016\/j.echo.2018.09.019","relation":{},"ISSN":["0894-7317"],"issn-type":[{"value":"0894-7317","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Echocardiography","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.echo.2018.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"2018 by the American Society of Echocardiography.","name":"copyright","label":"Copyright"}]}}